Traditional methods could only qualitatively detect the presence of the Y chromosome, failing to distinguish between male-male twins and male-female twins. They also lacked the capability to identify residual male cfDNA after fetal reduction procedures. Zentrogene’s NGS-based technology achieves three breakthroughs:
As a pioneer in Hong Kong’s genetic testing field, Zentrogene has established a global technology matrix covering pre-pregnancy, prenatal, and oncology applications through its integrated Sanger sequencing and NGS platforms. This NGS breakthrough underscores its ‘Technology-Driven Globalization’ strategy, leveraging Hong Kong’s expertise to deliver precision medical solutions worldwide. Zentrogene continues to advance genetic technology, safeguarding every family’s hopes with scientific rigor.
For details, visit:
https://www.zentrogene.com/
https://www.zentrogene.com.hk/
Official Cooperation Contacts:
Telephone: +86 18051865085 (WeChat same number)
Telegram: +855 99990026
Facebook: Zentrogene
Hashtag: #Zentrogene
The issuer is solely responsible for the content of this announcement.
VinFast has brought its decade-long care philosophy to the Middle East by pairing the VF…
BEIJING, CHINA - Media OutReach Newswire - 5 December 2025 - Peng Liyuan, wife of…
LONDON, UK - Media OutReach Newswire - 5 DECEMBER 2025 - Family wellbeing is emerging…
JAKARTA, INDONESIA - Media OutReach Newswire - 5 December 2025 - Green SM, Indonesia's first…
KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 5 December 2025 - For students preparing…
WUXI, CHINA - Media OutReach Newswire - 5 December 2025 - When UNESCO officially named…